Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

Autologous cell lines from circulating colon cancer cells captured from sequential liquid biopsies as model to study therapy-driven tumor changes.

Soler A, Cayrefourcq L, Mazard T, Babayan A, Lamy PJ, Assou S, Assenat E, Pantel K, Alix-Panabières C.

Sci Rep. 2018 Oct 29;8(1):15931. doi: 10.1038/s41598-018-34365-z.

2.

miRNA-30 Family Members Inhibit Breast Cancer Invasion, Osteomimicry, and Bone Destruction by Directly Targeting Multiple Bone Metastasis-Associated Genes.

Croset M, Pantano F, Kan CWS, Bonnelye E, Descotes F, Alix-Panabières C, Lecellier CH, Bachelier R, Allioli N, Hong SS, Bartkowiak K, Pantel K, Clézardin P.

Cancer Res. 2018 Sep 15;78(18):5259-5273. doi: 10.1158/0008-5472.CAN-17-3058. Epub 2018 Jul 24.

PMID:
30042152
3.

Chromosomal Aberrations Associated with Sequential Steps of the Metastatic Cascade in Colorectal Cancer Patients.

Joosse SA, Souche FR, Babayan A, Gasch C, Kerkhoven RM, Ramos J, Fabre JM, Riethdorf S, König A, Wikman H, Alix-Panabières C, Pantel K.

Clin Chem. 2018 Oct;64(10):1505-1512. doi: 10.1373/clinchem.2018.289819. Epub 2018 Jul 20.

PMID:
30030273
4.

Abstracts from the 11th International Symposium on Minimal Residual Disease, 3-5 May 2018, Montpellier, France.

Alix-Panabières C, Pantel K.

Clin Exp Metastasis. 2018 Jul 14. doi: 10.1007/s10585-018-9911-0. [Epub ahead of print] No abstract available.

PMID:
30008067
5.

11th International Symposium on Minimal Residual Cancer (ISMRC): 3-5 May 2018, Montpellier, France.

Alix-Panabières C, Pantel K.

Clin Exp Metastasis. 2018 Mar;35(3):87-90. doi: 10.1007/s10585-018-9909-7. Epub 2018 Jul 6. No abstract available.

PMID:
29980892
6.

Multiplex Gene Expression Profiling of In Vivo Isolated Circulating Tumor Cells in High-Risk Prostate Cancer Patients.

Markou A, Lazaridou M, Paraskevopoulos P, Chen S, Świerczewska M, Budna J, Kuske A, Gorges TM, Joosse SA, Kroneis T, Zabel M, Sedlmayr P, Alix-Panabières C, Pantel K, Lianidou ES.

Clin Chem. 2018 Feb;64(2):297-306. doi: 10.1373/clinchem.2017.275503. Epub 2017 Nov 9.

PMID:
29122836
7.

Detection of Circulating Plasma Cells in Multiple Myeloma.

Alix-Panabières C, Pantel K.

Clin Chem. 2017 Dec;63(12):1797-1798. doi: 10.1373/clinchem.2017.275446. Epub 2017 Sep 18. No abstract available.

PMID:
28923846
8.

Prognostic significance of PD-L1 expression on circulating tumor cells in patients with head and neck squamous cell carcinoma.

Strati A, Koutsodontis G, Papaxoinis G, Angelidis I, Zavridou M, Economopoulou P, Kotsantis I, Avgeris M, Mazel M, Perisanidis C, Sasaki C, Alix-Panabières C, Lianidou E, Psyrri A.

Ann Oncol. 2017 Aug 1;28(8):1923-1933. doi: 10.1093/annonc/mdx206.

PMID:
28838214
9.

EpCAM-Independent Enrichment and Detection of Viable Circulating Tumor Cells Using the EPISPOT Assay.

Soler A, Cayrefourcq L, Mazel M, Alix-Panabières C.

Methods Mol Biol. 2017;1634:263-276. doi: 10.1007/978-1-4939-7144-2_22.

PMID:
28819858
10.

Biological labels: Here comes the spaser.

Alix-Panabières C, Pantel K.

Nat Mater. 2017 Jul 26;16(8):790-791. doi: 10.1038/nmat4943. No abstract available.

PMID:
28748959
11.

Characterization of single circulating tumor cells.

Alix-Panabières C, Pantel K.

FEBS Lett. 2017 Aug;591(15):2241-2250. doi: 10.1002/1873-3468.12662. Epub 2017 May 27. Review.

12.

Tumour microenvironment: informing on minimal residual disease in solid tumours.

Pantel K, Alix-Panabières C.

Nat Rev Clin Oncol. 2017 Jun;14(6):325-326. doi: 10.1038/nrclinonc.2017.53. Epub 2017 Apr 11. No abstract available.

PMID:
28397823
13.

Liquid biopsy in 2016: Circulating tumour cells and cell-free DNA in gastrointestinal cancer.

Pantel K, Alix-Panabières C.

Nat Rev Gastroenterol Hepatol. 2017 Feb;14(2):73-74. doi: 10.1038/nrgastro.2016.198. Epub 2017 Jan 18. Review. No abstract available.

PMID:
28096542
14.

Epithelial-mesenchymal plasticity in circulating tumor cells.

Alix-Panabières C, Mader S, Pantel K.

J Mol Med (Berl). 2017 Feb;95(2):133-142. doi: 10.1007/s00109-016-1500-6. Epub 2016 Dec 24. Review.

PMID:
28013389
15.

Molecular Portrait of Metastasis-Competent Circulating Tumor Cells in Colon Cancer Reveals the Crucial Role of Genes Regulating Energy Metabolism and DNA Repair.

Alix-Panabières C, Cayrefourcq L, Mazard T, Maudelonde T, Assenat E, Assou S.

Clin Chem. 2017 Mar;63(3):700-713. doi: 10.1373/clinchem.2016.263582. Epub 2016 Dec 22.

16.

Improved detection of circulating tumor cells in non-metastatic high-risk prostate cancer patients.

Kuske A, Gorges TM, Tennstedt P, Tiebel AK, Pompe R, Preißer F, Prues S, Mazel M, Markou A, Lianidou E, Peine S, Alix-Panabières C, Riethdorf S, Beyer B, Schlomm T, Pantel K.

Sci Rep. 2016 Dec 21;6:39736. doi: 10.1038/srep39736.

17.

Circulating Tumor DNA as a Cancer Biomarker: Fact or Fiction?

Leung F, Kulasingam V, Diamandis EP, Hoon DS, Kinzler K, Pantel K, Alix-Panabières C.

Clin Chem. 2016 Aug;62(8):1054-60. doi: 10.1373/clinchem.2016.260331. Epub 2016 Jun 3. No abstract available.

18.

Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy.

Alix-Panabières C, Pantel K.

Cancer Discov. 2016 May;6(5):479-91. doi: 10.1158/2159-8290.CD-15-1483. Epub 2016 Mar 11. Review.

19.

Liquid biopsy: Potential and challenges.

Pantel K, Alix-Panabières C.

Mol Oncol. 2016 Mar;10(3):371-3. doi: 10.1016/j.molonc.2016.01.009. Epub 2016 Feb 1. No abstract available.

20.

Functional studies on circulating and disseminated tumor cells in carcinoma patients.

Alix-Panabières C, Bartkowiak K, Pantel K.

Mol Oncol. 2016 Mar;10(3):443-9. doi: 10.1016/j.molonc.2016.01.004. Epub 2016 Jan 18. Review.

21.

Cell lines from circulating tumor cells.

Pantel K, Alix-Panabières C.

Oncoscience. 2015 Aug 20;2(10):815-6. eCollection 2015. No abstract available.

22.

Functional Studies on Viable Circulating Tumor Cells.

Pantel K, Alix-Panabières C.

Clin Chem. 2016 Feb;62(2):328-34. doi: 10.1373/clinchem.2015.242537. Epub 2015 Dec 4. Review.

23.

Liquid biopsy in cancer patients: advances in capturing viable CTCs for functional studies using the EPISPOT assay.

Alix-Panabières C, Pantel K.

Expert Rev Mol Diagn. 2015;15(11):1411-7. doi: 10.1586/14737159.2015.1091729. Epub 2015 Sep 21. Review.

PMID:
26390240
24.

Frequent expression of PD-L1 on circulating breast cancer cells.

Mazel M, Jacot W, Pantel K, Bartkowiak K, Topart D, Cayrefourcq L, Rossille D, Maudelonde T, Fest T, Alix-Panabières C.

Mol Oncol. 2015 Nov;9(9):1773-82. doi: 10.1016/j.molonc.2015.05.009. Epub 2015 Jun 9.

25.

Establishment and characterization of a cell line from human circulating colon cancer cells.

Cayrefourcq L, Mazard T, Joosse S, Solassol J, Ramos J, Assenat E, Schumacher U, Costes V, Maudelonde T, Pantel K, Alix-Panabières C.

Cancer Res. 2015 Mar 1;75(5):892-901. doi: 10.1158/0008-5472.CAN-14-2613. Epub 2015 Jan 15.

26.

Bone marrow as a reservoir for disseminated tumor cells: a special source for liquid biopsy in cancer patients.

Pantel K, Alix-Panabières C.

Bonekey Rep. 2014 Nov 19;3:584. doi: 10.1038/bonekey.2014.79. eCollection 2014. Review.

27.

Challenges in circulating tumour cell research.

Alix-Panabières C, Pantel K.

Nat Rev Cancer. 2014 Sep;14(9):623-31. doi: 10.1038/nrc3820. Epub 2014 Jul 31. Review.

PMID:
25154812
28.

[The circulating tumor cells: liquid biopsy of cancer].

Alix-Panabieres C, Pantel K.

Klin Lab Diagn. 2014 Apr;(4):60-4. Review. Russian.

PMID:
25080805
29.

[Circulating tumor cells: cornerstone of personalized medicine].

Rafii A, Vidal F, Rathat G, Alix-Panabières C.

J Gynecol Obstet Biol Reprod (Paris). 2014 Nov;43(9):640-8. doi: 10.1016/j.jgyn.2014.06.009. Epub 2014 Jul 10. Review. French.

30.

[Circulating tumor cells: liquid biopsy].

Alix-Panabières C, Pierga JY.

Bull Cancer. 2014 Jan 1;101(1):17-23. doi: 10.1684/bdc.2014.1883. Review. French.

PMID:
24445939
31.

Prognostic relevance of viable circulating tumor cells detected by EPISPOT in metastatic breast cancer patients.

Ramirez JM, Fehm T, Orsini M, Cayrefourcq L, Maudelonde T, Pantel K, Alix-Panabières C.

Clin Chem. 2014 Jan;60(1):214-21. doi: 10.1373/clinchem.2013.215079. Epub 2013 Nov 19.

32.

Technologies for detection of circulating tumor cells: facts and vision.

Alix-Panabières C, Pantel K.

Lab Chip. 2014 Jan 7;14(1):57-62. doi: 10.1039/c3lc50644d. Epub 2013 Oct 21. Review.

PMID:
24145967
33.

Real-time liquid biopsy in cancer patients: fact or fiction?

Pantel K, Alix-Panabières C.

Cancer Res. 2013 Nov 1;73(21):6384-8. doi: 10.1158/0008-5472.CAN-13-2030. Epub 2013 Oct 21. Review.

34.

Real-time liquid biopsy: circulating tumor cells versus circulating tumor DNA.

Alix-Panabières C, Pantel K.

Ann Transl Med. 2013 Jul;1(2):18. doi: 10.3978/j.issn.2305-5839.2013.06.02.

35.

Capture of viable circulating tumor cells in the liver of colorectal cancer patients.

Denève E, Riethdorf S, Ramos J, Nocca D, Coffy A, Daurès JP, Maudelonde T, Fabre JM, Pantel K, Alix-Panabières C.

Clin Chem. 2013 Sep;59(9):1384-92. doi: 10.1373/clinchem.2013.202846. Epub 2013 May 21.

36.

Clinical application of circulating tumor cells in breast cancer: overview of the current interventional trials.

Bidard FC, Fehm T, Ignatiadis M, Smerage JB, Alix-Panabières C, Janni W, Messina C, Paoletti C, Müller V, Hayes DF, Piccart M, Pierga JY.

Cancer Metastasis Rev. 2013 Jun;32(1-2):179-88. doi: 10.1007/s10555-012-9398-0. Review.

37.

The potential of circulating tumor cells as a liquid biopsy to guide therapy in prostate cancer.

Pantel K, Alix-Panabières C.

Cancer Discov. 2012 Nov;2(11):974-5. doi: 10.1158/2159-8290.CD-12-0432. Epub 2012 Oct 23.

38.

Circulating tumor-derived biomarkers in lung cancer.

Taenzer A, Alix-Panabières C, Wikman H, Pantel K.

J Thorac Dis. 2012 Oct;4(5):448-9. doi: 10.3978/j.issn.2072-1439.2012.08.17. No abstract available.

39.

Detection methods of circulating tumor cells.

Pantel K, Alix-Panabières C.

J Thorac Dis. 2012 Oct;4(5):446-7. doi: 10.3978/j.issn.2072-1439.2012.08.15. No abstract available.

40.

Circulating tumor cells: liquid biopsy of cancer.

Alix-Panabières C, Pantel K.

Clin Chem. 2013 Jan;59(1):110-8. doi: 10.1373/clinchem.2012.194258. Epub 2012 Sep 26. Review.

41.

Plasticity of disseminating cancer cells in patients with epithelial malignancies.

Bednarz-Knoll N, Alix-Panabières C, Pantel K.

Cancer Metastasis Rev. 2012 Dec;31(3-4):673-87. doi: 10.1007/s10555-012-9370-z. Review.

PMID:
22733306
42.

[Circulating tumor cells and advanced prostate cancer].

Murez T, Droupy S, Rebillard X, Alix-Panabieres C.

Bull Cancer. 2012 Jul;99 Suppl 1:S4-15. doi: 10.1684/bdc.2012.1565. Review. French.

PMID:
22569300
43.

EPISPOT assay: detection of viable DTCs/CTCs in solid tumor patients.

Alix-Panabières C.

Recent Results Cancer Res. 2012;195:69-76. doi: 10.1007/978-3-642-28160-0_6. Review.

PMID:
22527495
44.

Circulating epithelial cells in patients with benign colon diseases.

Pantel K, Denève E, Nocca D, Coffy A, Vendrell JP, Maudelonde T, Riethdorf S, Alix-Panabières C.

Clin Chem. 2012 May;58(5):936-40. doi: 10.1373/clinchem.2011.175570. Epub 2011 Dec 28.

45.

Clinical relevance and biology of circulating tumor cells.

Bednarz-Knoll N, Alix-Panabières C, Pantel K.

Breast Cancer Res. 2011;13(6):228. doi: 10.1186/bcr2940. Epub 2011 Nov 1. Review.

46.

Circulating tumor cells and circulating tumor DNA.

Alix-Panabières C, Schwarzenbach H, Pantel K.

Annu Rev Med. 2012;63:199-215. doi: 10.1146/annurev-med-062310-094219. Epub 2011 Nov 2. Review.

PMID:
22053740
47.

Circulating tumor cells in prostate cancer: a potential surrogate marker of survival.

Doyen J, Alix-Panabières C, Hofman P, Parks SK, Chamorey E, Naman H, Hannoun-Lévi JM.

Crit Rev Oncol Hematol. 2012 Mar;81(3):241-56. doi: 10.1016/j.critrevonc.2011.05.004. Epub 2011 Jun 15. Review.

PMID:
21680196
48.

Molecular mechanisms of metastasis.

Hoon DS, Ferris R, Tanaka R, Chong KK, Alix-Panabières C, Pantel K.

J Surg Oncol. 2011 May 1;103(6):508-17. doi: 10.1002/jso.21690. Review.

PMID:
21480243
49.

Circulating tumour cells in cancer patients: challenges and perspectives.

Pantel K, Alix-Panabières C.

Trends Mol Med. 2010 Sep;16(9):398-406. doi: 10.1016/j.molmed.2010.07.001. Epub 2010 Jul 29. Review.

PMID:
20667783
50.

Insights into minimal residual disease in cancer patients: implications for anti-cancer therapies.

Müller V, Alix-Panabières C, Pantel K.

Eur J Cancer. 2010 May;46(7):1189-97. doi: 10.1016/j.ejca.2010.02.038. Epub 2010 Mar 27. Review.

PMID:
20347588

Supplemental Content

Loading ...
Support Center